clopidogrel has been researched along with Aortic Stenosis in 39 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (5.13) | 29.6817 |
2010's | 24 (61.54) | 24.3611 |
2020's | 13 (33.33) | 2.80 |
Authors | Studies |
---|---|
Grunebaum, L; Heger, J; Hess, S; Jesel, L; Kibler, M; Marchandot, B; Matsushita, K; Morel, O; Ohana, M; Ohlmann, P; Peillex, M; Reydel, A; Trimaille, A | 1 |
Falster, MO; Jorm, LR; Kushwaha, VV; Pearson, SA; Sedrakyan, A; Sotade, OT; Yu, J | 1 |
Ashley, KE; Hillegass, WB | 1 |
Feit, F | 1 |
Lim, GB | 1 |
Belley-Côté, EP; Eikelboom, R; Whitlock, RP | 1 |
Anwar, S; Spence, E; Zawadka, M | 1 |
Fahrni, G; Jeger, R; Mueller, C | 1 |
Ahmad, B; Alraies, MC; Biswas, S; Fichman, DL; Goldsweig, AM; Pacha, HM; Prasad, A; Sattar, Y; Ullah, W; Velagapudi, P; Zaher, N; Zghouzi, M | 1 |
Ben-Dor, I; Case, BC; Forrestal, BJ; Mintz, GS; Rogers, T; Satler, LF; Waksman, R; Yerasi, C | 1 |
Fukuda, K; Hayashida, K; Inohara, T; Kobari, Y; Mizutani, K; Naganuma, T; Saito, T; Shimizu, H; Shirai, S; Tabata, M; Tada, N; Takagi, K; Tanaka, M; Tsuruta, H; Ueno, H; Watanabe, Y; Yamamoto, M; Yamanaka, F; Yamawaki, M; Yashima, F; Yoshijima, N | 1 |
Bastos-Fernandez, G; Baz-Alonso, JA; Cruz-González, I; De Miguel-Castro, A; Fernández-Barbeira, S; Figueiras-Guzman, A; Iñiguez-Romo, A; Jimenez-Diaz, VA; Molina-Navarro, E; Moreno, R; Ortiz-Saez, A; Paredes-Galán, E; Romaguera, R; Salvadores, PJ; Tello-Montoliu, A; Trejo-Velasco, B | 1 |
Adlbrecht, C; Cuhaj, C; Delle-Karth, G; Grabenwöger, M; Hasan, W; Mach, M; Poschner, T; Strouhal, A; Szalkiewicz, P; Watzal, V; Winkler, B | 1 |
Aznaouridis, K; Bei, E; Iakovou, I; Kalantzis, C; Kalogeras, K; Katsianos, E; Kosmas, E; Leucker, TM; Moldovan, CM; Oikonomou, E; Papaioannou, TG; Siasos, G; Stasinopoulou, M; Tountopoulou, A; Tousoulis, D; Toutouzas, K; Vavuranakis, M; Vavuranakis, MA; Voudris, V; Vrachatis, D | 1 |
Abdel-Wahab, M; Allali, A; El-Mawardy, M; Holy, EW; Kebernik, J; Richardt, G | 1 |
Barbieri, L; De Luca, G; Nardin, M; Suryapranata, H; Verdoia, M | 1 |
Bastos Fernandez, G; Baz Alonso, JA; Calvo Iglesias, F; Cequier Fillat, A; Cruz Gonzalez, I; De Miguel Castro, A; Fernandez Barbeira, S; Iñiguez Romo, A; Jimenez Diaz, VA; Juan Salvadores, P; Molina Navarro, E; Moreno, R; Ocampo Miguez, J; Ortiz Saez, A; Paredes Galan, E; Raposeiras Roubin, S; Romaguera, R; Serra Peñaranda, A; Tello-Montoliu, A; Valdes Chavarri, M | 1 |
Claessen, BE; Collet, JP; Dangas, GD; Guedeney, P; Mehran, R; Ten Berg, J | 1 |
Anthopoulos, P; Chandrasekhar, J; Claessen, B; Colombo, A; Dangas, G; Deliargyris, EN; Hengstenberg, C; Hildick-Smith, D; Hink, HU; Kupatt, C; Lefèvre, T; Mehran, R; Nijenhuis, VJ; Sartori, S; Ten Berg, JM; Tron, C; Van Belle, E; Windecker, S | 1 |
Baz Alonso, JA; Calvo Iglesias, F; Iñiguez Romo, A; Jimenez Diaz, VA; Lozano, I | 1 |
Dantzler, D; Lynch, DR; Robbins, M; Zhao, D | 1 |
Musumeci, F; Pergolini, A; Pino, PG; Polizzi, V; Zampi, G | 1 |
Cohen, DJ; Généreux, P; Hahn, R; Kodali, SK; Leon, MB; Mack, M; Parvataneni, R; Rodes-Cabau, J; Webb, JG; Xu, K; Yadav, M | 1 |
Kazi, DS | 1 |
Kalogeras, K; Kariori, M; Kolokathis, AM; Lavda, M; Moldovan, C; Mpei, E; Siasos, G; Tousoulis, D; Vavuranakis, M; Vrachatis, D | 1 |
Farkouh, ME; Gandhi, S; Natarajan, MK; Schwalm, JD; Velianou, JL | 1 |
Baan, J; Barbanti, M; Blanchard, D; Delewi, R; Durand, E; Eltchaninoff, H; Hassell, ME; Hildick-Smith, D; Kikkert, WJ; Piek, JJ; Poliacikova, P; Rubino, P; Sharma, S; Stabile, E; Tamburino, C; Ussia, GP; Wiegerinck, EM | 1 |
Iung, B | 1 |
Neumann, FJ; Pache, G; Ruile, P; Schoechlin, S | 1 |
Assali, A; Codner, P; Eisen, A; Kornowski, R; Lev, EI; Orvin, K; Perl, L; Vaknin-Assa, H; Zemer-Wassercug, N | 1 |
Azmoun, A; Ben Ouanes, S; Fradi, S; Ghostine, S; Magkoutis, NA; Papaioannou, TG; Ramadan, R; Tousoulis, D; Vavuranakis, M; Vrachatis, DA | 1 |
Agostoni, P; Baan, J; Bennaghmouch, N; Collet, JP; den Heijer, P; Deneer, VH; Hassell, M; Huber, K; Kelder, JC; Kievit, PC; Latib, A; Maisano, F; Nijenhuis, VJ; Onorati, F; Stella, PR; Ten Berg, JM; van 't Hof, A; van den Heuvel, AF; van der Harst, P; van der Kley, F; van Kuijk, JP; Veenstra, L | 1 |
Hosogoe, N; Ishikawa, S; Isshiki, T; Kozuma, K; Watanabe, Y | 1 |
Baber, U; Dangas, GD; Giustino, G; Guimarães, AH; Hemmrich, M; Mehran, R; Thomitzek, K; Tijssen, J; Valgimigli, M; van Es, GA; Volkl, AA; Vranckx, P; Welsh, RC; Wildgoose, P; Windecker, S; Zazula, A | 1 |
Benedetti, G; De Carlo, M; Donne, MG; Giannini, C; Guarracino, F; Petronio, AS; Verunelli, F | 1 |
Aruta, P; Barbanti, M; Cammalleri, V; Capodanno, D; Deste, W; Gulino, S; Immè, S; Mulè, M; Pistritto, AM; Sarkar, K; Scarabelli, M; Tamburino, C; Ussia, GP | 1 |
Al-Rashid, F; Erbel, R; Jakob, H; Kahlert, P; Konorza, TF; Plicht, B; Thielmann, M; Wendt, D | 1 |
Buellesfeld, L; Felderhoff, T; Gerckens, U; Grube, E; Iversen, S; Laborde, JC; Menichelli, M; Mueller, R; Sauren, B; Schmidt, T; Stone, GW; Zickmann, B | 1 |
Baim, DS; Brinster, DR; Byrne, M; Cohn, LH; Couper, GS; Rogers, CD; Simon, DI | 1 |
7 review(s) available for clopidogrel and Aortic Stenosis
Article | Year |
---|---|
Meta-Analysis Comparing the Safety and Efficacy of Single vs Dual Antiplatelet Therapy in Post Transcatheter Aortic Valve Implantation Patients.
Topics: Aortic Valve Stenosis; Aspirin; Clopidogrel; Dual Anti-Platelet Therapy; Hemorrhage; Humans; Ischemic Attack, Transient; Myocardial Infarction; Odds Ratio; Platelet Aggregation Inhibitors; Postoperative Care; Stroke; Thrombosis; Transcatheter Aortic Valve Replacement | 2021 |
Usefulness of Antiplatelet Therapy After Transcatheter Aortic Valve Implantation.
Topics: Aortic Valve Stenosis; Aspirin; Cause of Death; Clopidogrel; Dual Anti-Platelet Therapy; Endothelium; Evidence-Based Medicine; Hemorrhage; Humans; Mortality; Platelet Aggregation Inhibitors; Stroke; Thrombosis; Transcatheter Aortic Valve Replacement | 2021 |
Dual Versus Single Antiplatelet Regimen With or Without Anticoagulation in Transcatheter Aortic Valve Replacement: Indirect Comparison and Meta-analysis.
Topics: Anticoagulants; Aortic Valve; Aortic Valve Stenosis; Aspirin; Clopidogrel; Drug Therapy, Combination; Heart Valve Prosthesis; Humans; Platelet Aggregation Inhibitors; Ticlopidine; Transcatheter Aortic Valve Replacement; Treatment Outcome | 2018 |
Antithrombotic Therapy After Transcatheter Aortic Valve Replacement.
Topics: Anticoagulants; Aortic Valve Stenosis; Aspirin; Clopidogrel; Drug Administration Schedule; Drug Therapy, Combination; Fibrinolytic Agents; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Risk Assessment; Risk Factors; Transcatheter Aortic Valve Replacement; Treatment Outcome | 2019 |
Considerations in antithrombotic therapy among patients undergoing transcatheter aortic valve implantation.
Topics: Aortic Valve Stenosis; Aspirin; Cardiac Catheterization; Clopidogrel; Fibrinolytic Agents; Heart Valve Prosthesis; Humans; Myocardial Ischemia; Platelet Aggregation Inhibitors; Postoperative Complications; Practice Guidelines as Topic; Ticlopidine; Time Factors | 2013 |
Comparison of Dual-antiplatelet Therapy to Mono-antiplatelet Therapy After Transcatheter Aortic Valve Implantation: Systematic Review and Meta-analysis.
Topics: Aged; Aged, 80 and over; Aortic Valve Stenosis; Aspirin; Clopidogrel; Drug Therapy, Combination; Female; Humans; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Postoperative Care; Postoperative Complications; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Stroke; Survival Analysis; Ticlopidine; Transcatheter Aortic Valve Replacement; Treatment Outcome; Ultrasonography | 2015 |
Antiplatelet therapy following transcatheter aortic valve implantation.
Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Aortic Valve Stenosis; Aspirin; Cardiac Catheterization; Clopidogrel; Drug Therapy, Combination; Female; Heart Valve Prosthesis Implantation; Hemorrhage; Humans; Male; Odds Ratio; Platelet Aggregation Inhibitors; Risk Assessment; Risk Factors; Stroke; Ticlopidine; Time Factors; Treatment Outcome | 2015 |
9 trial(s) available for clopidogrel and Aortic Stenosis
Article | Year |
---|---|
Impact of Comorbidities and Antiplatelet Regimen on Platelet Reactivity Levels in Patients Undergoing Transcatheter Aortic Valve Implantation.
Topics: Aged; Aged, 80 and over; Anemia; Aortic Valve Stenosis; Aspirin; Blood Platelets; Clopidogrel; Comorbidity; Diabetes Mellitus; Dual Anti-Platelet Therapy; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Function Tests; Prevalence; Prospective Studies; Renal Insufficiency, Chronic; Severity of Illness Index; Spain; Ticagrelor; Time Factors; Transcatheter Aortic Valve Replacement; Treatment Outcome | 2021 |
Comparison of Ticagrelor Versus Clopidogrel on Cerebrovascular Microembolic Events and Platelet Inhibition during Transcatheter Aortic Valve Implantation.
Topics: Aged; Aged, 80 and over; Aortic Valve Stenosis; Aspirin; Clopidogrel; Dual Anti-Platelet Therapy; Female; Humans; Intracranial Embolism; Intraoperative Complications; Male; Platelet Aggregation Inhibitors; Ticagrelor; Transcatheter Aortic Valve Replacement; Ultrasonography, Doppler, Transcranial | 2021 |
Assessment of Platelet REACtivity After Transcatheter Aortic Valve Replacement: The REAC-TAVI Trial.
Topics: Aged; Aged, 80 and over; Aortic Valve; Aortic Valve Stenosis; Aspirin; Blood Platelets; Clopidogrel; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pilot Projects; Platelet Aggregation Inhibitors; Prospective Studies; Registries; Spain; Ticagrelor; Time Factors; Treatment Outcome | 2019 |
Usefulness of Clopidogrel Loading in Patients Who Underwent Transcatheter Aortic Valve Implantation (from the BRAVO-3 Randomized Trial).
Topics: Aged, 80 and over; Aortic Valve Stenosis; Clopidogrel; Dose-Response Relationship, Drug; Europe; Female; Follow-Up Studies; Humans; Incidence; Male; North America; Postoperative Complications; Preoperative Care; Prospective Studies; Purinergic P2Y Receptor Antagonists; Risk Assessment; Risk Factors; Thromboembolism; Time Factors; Transcatheter Aortic Valve Replacement | 2019 |
Incidence, predictors, and prognostic impact of late bleeding complications after transcatheter aortic valve replacement.
Topics: Aged; Aged, 80 and over; Aortic Valve Stenosis; Aspirin; Clopidogrel; Echocardiography; Female; Follow-Up Studies; Hemorrhage; Humans; Incidence; Kaplan-Meier Estimate; Male; Outcome Assessment, Health Care; Platelet Aggregation Inhibitors; Prognosis; Risk Assessment; Severity of Illness Index; Survival Rate; Ticlopidine; Transcatheter Aortic Valve Replacement | 2014 |
Rationale and design of POPular-TAVI: antiPlatelet therapy fOr Patients undergoing Transcatheter Aortic Valve Implantation.
Topics: Administration, Oral; Aortic Valve Stenosis; Aspirin; Clopidogrel; Dose-Response Relationship, Drug; Drug Therapy, Combination; Europe; Follow-Up Studies; Humans; Incidence; Platelet Aggregation Inhibitors; Postoperative Complications; Preoperative Care; Prospective Studies; Survival Rate; Thromboembolism; Ticlopidine; Time Factors; Transcatheter Aortic Valve Replacement; Treatment Outcome | 2016 |
Trial design: Rivaroxaban for the prevention of major cardiovascular events after transcatheter aortic valve replacement: Rationale and design of the GALILEO study.
Topics: Aortic Valve Stenosis; Aspirin; Cardiovascular Diseases; Cause of Death; Clopidogrel; Drug Therapy, Combination; Embolism; Factor Xa Inhibitors; Heart Valve Diseases; Humans; Mortality; Myocardial Infarction; Platelet Aggregation Inhibitors; Postoperative Care; Pulmonary Embolism; Rivaroxaban; Stroke; Thrombosis; Ticlopidine; Transcatheter Aortic Valve Replacement; Venous Thrombosis | 2017 |
Dual antiplatelet therapy versus aspirin alone in patients undergoing transcatheter aortic valve implantation.
Topics: Aged, 80 and over; Aortic Valve; Aortic Valve Stenosis; Aspirin; Catheters; Clopidogrel; Drug Therapy, Combination; Female; Heart Valve Prosthesis Implantation; Humans; Male; Platelet Aggregation Inhibitors; Severity of Illness Index; Single-Blind Method; Ticlopidine | 2011 |
Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study.
Topics: Aged; Aged, 80 and over; Aortic Valve; Aortic Valve Insufficiency; Aortic Valve Stenosis; Bioprosthesis; Clopidogrel; Echocardiography; Female; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Hemodynamics; Humans; Male; Platelet Aggregation Inhibitors; Prospective Studies; Risk Factors; Stents; Thrombocytopenia; Ticlopidine; Treatment Outcome | 2006 |
23 other study(ies) available for clopidogrel and Aortic Stenosis
Article | Year |
---|---|
P2Y
Topics: Aortic Valve; Aortic Valve Stenosis; Clopidogrel; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Risk Factors; Transcatheter Aortic Valve Replacement; Treatment Outcome | 2022 |
Post-Discharge Antithrombotic Therapy Following Transcatheter Aortic Valve Implantation in Australian Patients.
Topics: Aftercare; Aged, 80 and over; Anticoagulants; Aortic Valve; Aortic Valve Stenosis; Australia; Clopidogrel; Female; Fibrinolytic Agents; Humans; Male; Patient Discharge; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Transcatheter Aortic Valve Replacement; Treatment Outcome; Warfarin | 2022 |
Clopidogrel pretreatment may reduce early acquired thrombocytopenia after transcatheter aortic valve replacement (TAVR).
Topics: Aortic Valve Stenosis; Clopidogrel; Humans; Platelet Count; Risk Factors; Thrombocytopenia; Time Factors; Transcatheter Aortic Valve Replacement; Treatment Outcome | 2019 |
How Un-POPular Is Bleeding in Patients with TAVI?
Topics: Anticoagulants; Aortic Valve Stenosis; Clopidogrel; Hemorrhage; Humans; Transcatheter Aortic Valve Replacement | 2020 |
Antithrombotic therapy after TAVI.
Topics: Anticoagulants; Aortic Valve; Aortic Valve Stenosis; Clopidogrel; Fibrinolytic Agents; Humans; Transcatheter Aortic Valve Replacement | 2020 |
Single or Dual Antiplatelet Treatment after TAVI.
Topics: Aortic Valve Stenosis; Aspirin; Clopidogrel; Humans; Platelet Aggregation Inhibitors; Transcatheter Aortic Valve Replacement | 2021 |
Single or Dual Antiplatelet Treatment after TAVI.
Topics: Aortic Valve Stenosis; Aspirin; Clopidogrel; Humans; Platelet Aggregation Inhibitors; Transcatheter Aortic Valve Replacement | 2021 |
Single or Dual Antiplatelet Treatment after TAVI.
Topics: Aortic Valve Stenosis; Aspirin; Clopidogrel; Humans; Platelet Aggregation Inhibitors; Transcatheter Aortic Valve Replacement | 2021 |
Aspirin Versus Clopidogrel as Single Antithrombotic Therapy After Transcatheter Aortic Valve Replacement: Insight From the OCEAN-TAVI Registry.
Topics: Aortic Valve; Aortic Valve Stenosis; Aspirin; Clopidogrel; Fibrinolytic Agents; Humans; Platelet Aggregation Inhibitors; Registries; Risk Factors; Transcatheter Aortic Valve Replacement; Treatment Outcome | 2021 |
The impact of antiplatelet and antithrombotic regimen after TAVI: Data from the VIenna CardioThOracic Aortic Valve RegistrY (VICTORY).
Topics: Aged; Aged, 80 and over; Anticoagulants; Aortic Valve Stenosis; Aspirin; Austria; Clopidogrel; Dual Anti-Platelet Therapy; Factor Xa Inhibitors; Female; Fibrinolytic Agents; Hemorrhage; Humans; Male; Platelet Aggregation Inhibitors; Postoperative Care; Registries; Survival Rate; Transcatheter Aortic Valve Replacement; Vitamin K | 2021 |
Comparison of dual antiplatelet therapy versus oral anticoagulation following transcatheter aortic valve replacement: A retrospective single-center registry analysis.
Topics: Administration, Oral; Aged, 80 and over; Aortic Valve; Aortic Valve Stenosis; Aspirin; Clopidogrel; Drug Therapy, Combination; Echocardiography; Female; Follow-Up Studies; Humans; Male; Platelet Aggregation Inhibitors; Registries; Retrospective Studies; Thrombolytic Therapy; Thrombosis; Transcatheter Aortic Valve Replacement; Treatment Outcome | 2017 |
HALT After TAVR: Searching the Bases, Finding the Cusp.
Topics: Aortic Valve; Aortic Valve Stenosis; Clopidogrel; Humans; Incidence; Transcatheter Aortic Valve Replacement; Treatment Outcome | 2019 |
Thrombotic aortic restenosis after transapical SAPIEN valve implantation.
Topics: Aged, 80 and over; Anticoagulants; Aortic Valve Stenosis; Aspirin; Bioprosthesis; Clopidogrel; Echocardiography, Transesophageal; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Heparin; Humans; Male; Prosthesis Failure; Recurrence; Thrombosis; Ticlopidine; Treatment Outcome | 2014 |
From innovation to implementation: optimizing long-term outcomes after TAVR.
Topics: Aortic Valve Stenosis; Aspirin; Clopidogrel; Female; Hemorrhage; Humans; Male; Ticlopidine; Transcatheter Aortic Valve Replacement | 2014 |
Antithrombotic therapy in patients undergoing TAVI with concurrent atrial fibrillation. One center experience.
Topics: Acenocoumarol; Aged; Aged, 80 and over; Aortic Valve Stenosis; Atrial Fibrillation; Clopidogrel; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Male; Ticlopidine; Transcatheter Aortic Valve Replacement | 2015 |
Antithrombotic therapy after transcatheter aortic valve implantation.
Topics: Aortic Valve Stenosis; Aspirin; Cardiac Catheterization; Clopidogrel; Female; Heart Valve Prosthesis Implantation; Humans; Male; Platelet Aggregation Inhibitors; Ticlopidine | 2015 |
Early hypoattenuated leaflet thickening and restricted leaflet motion of a Lotus transcatheter heart valve detected by 4D computed tomography angiography.
Topics: Aged, 80 and over; Anticoagulants; Aortic Valve Stenosis; Clopidogrel; Coronary Angiography; Female; Four-Dimensional Computed Tomography; Heart Valve Prosthesis; Humans; Phenprocoumon; Platelet Aggregation Inhibitors; Prosthesis Failure; Thrombosis; Ticlopidine; Transcatheter Aortic Valve Replacement | 2015 |
Platelet reactivity in patients undergoing transcatheter aortic valve implantation.
Topics: Aged; Aged, 80 and over; Aortic Valve Stenosis; Aspirin; Clopidogrel; Drug Therapy, Combination; Female; Humans; Male; Platelet Activation; Platelet Aggregation Inhibitors; Thromboembolism; Ticlopidine; Transcatheter Aortic Valve Replacement; Warfarin | 2016 |
Antiplatelet Therapy in TAVI: Current Clinical Practice and Recommendations.
Topics: Administration, Oral; Anticoagulants; Aortic Valve Stenosis; Aspirin; Clopidogrel; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Ticlopidine; Transcatheter Aortic Valve Replacement | 2016 |
Hyper-Response to Clopidogrel in Japanese Patients Undergoing Transcatheter Aortic Valve Implantation.
Topics: Aged, 80 and over; Aortic Valve Stenosis; Clopidogrel; Cytochrome P-450 CYP2C19; Female; Follow-Up Studies; Genotype; Humans; Japan; Male; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Point-of-Care Systems; Postoperative Complications; Prognosis; Prospective Studies; Thrombosis; Ticlopidine; Transcatheter Aortic Valve Replacement | 2016 |
Dysfunction of a 21-mm aortic bioprosthesis treated with percutaneous implantation of a CoreValve prosthesis.
Topics: Aged, 80 and over; Aortic Valve; Aortic Valve Stenosis; Aspirin; Calcinosis; Clopidogrel; Combined Modality Therapy; Echocardiography; Echocardiography, Transesophageal; Female; Follow-Up Studies; Heart Valve Prosthesis Implantation; Humans; Platelet Aggregation Inhibitors; Prosthesis Failure; Risk Factors; Ticlopidine; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Transient increase in pressure gradients after termination of dual antiplatelet therapy in a patient after transfemoral aortic valve implantation.
Topics: Aged; Aortic Valve Stenosis; Aspirin; Cardiac Catheterization; Clopidogrel; Dyspnea; Echocardiography, Doppler; Femoral Artery; Heart Valve Prosthesis Implantation; Hemodynamics; Humans; Male; Platelet Aggregation Inhibitors; Recovery of Function; Ticlopidine; Withholding Treatment | 2012 |
Effectiveness of same day percutaneous coronary intervention followed by minimally invasive aortic valve replacement for aortic stenosis and moderate coronary disease ("hybrid approach").
Topics: Aged; Aged, 80 and over; Aortic Valve; Aortic Valve Stenosis; Aspirin; Clopidogrel; Coronary Disease; Elective Surgical Procedures; Female; Humans; Male; Middle Aged; Minimally Invasive Surgical Procedures; Prospective Studies; Stents; Ticlopidine | 2006 |